4 : 237247 Pettegrew JW, Woessner DE, Minshew NJ
The lameness period (an indicator of joint pain and dysfunction) was significantly shorter in animals receiving AOD-9604 plus hyaluronic acid compared to other treatment groups
Li N, Liu W, Zheng X, Wang Q, Shen L, Hui J, et al
You've seen them sold online as "research chemicals" and wonder if that's just a loophole
"Effects of Tesamorelin on Nonalcoholic Fatty Liver Disease in HIV." JAMA
They are not simply two names for the same healing peptide. The clearest way to see the divergence is by the kind of neuro-outcome each is best evidenced for: BPC-157 is best supported for peripheral-nerve regeneration and CNS neuroprotection : accelerating axonal regrowth in transected peripheral nerve, sparing tissue and limiting edema after brain and spinal-cord injury, and supporting repair through VEGFR2/NO-mediated angiogenesis, with an additional braingut neuromodulatory layer